Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Leon

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
Experimental Parasitology|December 11, 2012
The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivativesKaren S Charret, Jussara Lagrota-Cândido, Carla E Carvalho-Pinto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 24, 2017
PrediCTC, liquid biopsy in precision oncology: a technology transfer experience in the Spanish health systemL Alonso-Alconada, J Barbazan, S Candamio, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
3-[4'-bromo-(1,1'-biphenyl)-4-yl]-N, N-dimethyl-3-(2-thienyl)-2-propen-1-amine: synthesis, cytotoxicity, and leishmanicidal, trypanocidal and antimycobacterial activitiesAna O de Souza, Fernando P Hemerly, Adriana C Busollo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 17, 2021
Electronic health records and patient registries in medical oncology departments in SpainN Ribelles, I Alvarez-Lopez, A Arcusa, et al.
Molecules (Basel, Switzerland)|November 3, 2012
4-(1H-Pyrazol-1-yl) benzenesulfonamide derivatives: identifying new active antileishmanial structures for use against a neglected diseaseRoberta K F Marra, Alice M R Bernardino, Tathiane A Proux, et al.
American Journal of Human Genetics|August 19, 2014
Mutations in NOTCH1 cause Adams-Oliver syndromeAnna-Barbara Stittrich, Anna Lehman, Dale L Bodian, et al.
Annals of Emergency Medicine|October 3, 2006
ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injuryDavid W Wright, Arthur L Kellermann, Vicki S Hertzberg, et al.
American Journal of Medical Genetics. Part A|February 21, 2018
Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndromeLeonie A Menke, , Thatjana Gardeitchik, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 12, 2014
Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for EuropeW Van Bortel, F Dorleans, J Rosine, et al.
Current Medicinal Chemistry|March 15, 2012
The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part IT J Schmidt, S A Khalid, A J Romanha, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Experimental Parasitology|December 11, 2012
The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivativesKaren S Charret, Jussara Lagrota-Cândido, Carla E Carvalho-Pinto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 24, 2017
PrediCTC, liquid biopsy in precision oncology: a technology transfer experience in the Spanish health systemL Alonso-Alconada, J Barbazan, S Candamio, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
3-[4'-bromo-(1,1'-biphenyl)-4-yl]-N, N-dimethyl-3-(2-thienyl)-2-propen-1-amine: synthesis, cytotoxicity, and leishmanicidal, trypanocidal and antimycobacterial activitiesAna O de Souza, Fernando P Hemerly, Adriana C Busollo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 17, 2021
Electronic health records and patient registries in medical oncology departments in SpainN Ribelles, I Alvarez-Lopez, A Arcusa, et al.
Molecules (Basel, Switzerland)|November 3, 2012
4-(1H-Pyrazol-1-yl) benzenesulfonamide derivatives: identifying new active antileishmanial structures for use against a neglected diseaseRoberta K F Marra, Alice M R Bernardino, Tathiane A Proux, et al.
American Journal of Human Genetics|August 19, 2014
Mutations in NOTCH1 cause Adams-Oliver syndromeAnna-Barbara Stittrich, Anna Lehman, Dale L Bodian, et al.
Annals of Emergency Medicine|October 3, 2006
ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injuryDavid W Wright, Arthur L Kellermann, Vicki S Hertzberg, et al.
American Journal of Medical Genetics. Part A|February 21, 2018
Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndromeLeonie A Menke, , Thatjana Gardeitchik, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 12, 2014
Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for EuropeW Van Bortel, F Dorleans, J Rosine, et al.
Current Medicinal Chemistry|March 15, 2012
The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part IT J Schmidt, S A Khalid, A J Romanha, et al.
Pageof 21